Entera Bio
€0.92
39
+€0.08+8.96% Wednesday 06:09
Statistics
Day High
0.92
Day Low
0.92
52W High
2.66
52W Low
0.84
Volume
-
Avg. Volume
-
Mkt Cap
42.37M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
8MayExpected
Expected EPS
-0.11
Actual EPS
N/A
Financials
-5,240.27%Profit Margin
Unprofitable344,993.25Revenue
-18.08MNet Income
Analyst Ratings
$7.59Average Price Target
The highest estimate is 7.59.
From 1 ratings within the last 6 months. This is not an investment recommendation.
From 1 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 5DT.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
AMGEN
AMGN
Mkt Cap160.66B
Abbvie
ABBV
Mkt Cap385.18B
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
Pfizer
PFE
Mkt Cap140.15B
Novo Nordisk
NVO
Mkt Cap217.54B
Regeneron Pharmaceuticals
REGN
Mkt Cap68.5B
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Gilead Sciences
GILD
Mkt Cap148.78B
About
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product candidates include the EB612, which is in Phase II clinical trials for the treatment of hypoparathyroidism; and EB613 that has completed Phase II clinical trials for the treatment of osteoporosis, as well as is in Phase I clinical trials for the treatment of non-union fractures. The company has a research collaboration and license agreement with the Amgen Inc. for the development and discovery of clinical candidates in the field of inflammatory disease and other serious illnesses. Entera Bio Ltd. was incorporated in 2009 and is based in Jerusalem, Israel.
Show more...
CEO
Ms. Miranda J. Toledano M.B.A.
Employees
19
Country
IL
ISIN
IL0011429839
WKN
000A2JQXP
Listings
0 Comments
Share your thoughts
FAQ
What is Entera Bio stock price today?▼
The current price of 5DT.F is €0.92 EUR — it has increased by +8.96% in the past 24 hours. Watch Entera Bio stock price performance more closely on the chart.
What is Entera Bio stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Entera Bio stocks are traded under the ticker 5DT.F.
Is Entera Bio stock price growing?▼
5DT.F stock has risen by +4.76% compared to the previous week, the month change is a -16.91% fall, over the last year Entera Bio has showed a -35.83% decrease.
What is Entera Bio market cap?▼
Today Entera Bio has the market capitalization of 42.37M
When is the next Entera Bio earnings date?▼
Entera Bio is going to release the next earnings report on May 08, 2026.
What were Entera Bio earnings last quarter?▼
5DT.F earnings for the last quarter are -0.06 EUR per share, whereas the estimation was -0.08 EUR resulting in a +22.22% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Entera Bio revenue for the last year?▼
Entera Bio revenue for the last year amounts to 344,993.25 EUR.
What is Entera Bio net income for the last year?▼
5DT.F net income for the last year is -18.08M EUR.
How many employees does Entera Bio have?▼
As of April 04, 2026, the company has 19 employees.
When did Entera Bio complete a stock split?▼
Entera Bio has not had any recent stock splits.
Where is Entera Bio headquartered?▼
Entera Bio is headquartered in Jerusalem, IL.